The Effects of Senolytics in Animal Models of PF | Cory Hogaboam, PhD

Cory Hogaboam, PhD of Cedars-Sinai discusses the several mechanisms that appear to account for cellular senescence in IPF as well as the benefits, consequences, and future challenges of cellular senescence. Social media platforms - Twitter - @PFFORG Facebook - @PFFORG Instagram - @PFFORG LinkedIn- Pulmonary Fibrosis Foundation Please note that any information contained in this presentation is for informational and/or educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition. This presentation is protected by U.S. and International copyright laws. Reproductions and distribution of this presentation without written permission from the Pulmonary Fibrosis Foundation is prohibited. © 2020 Pulmonary Fibrosis Foundation